MLB: Rays place OF Josh Lowe (oblique) on 10-day IL

Date:

Share post:


The Tampa Bay Rays placed outfielder Josh Lowe on the 10-day injured list Saturday with a right oblique strain.

The move is retroactive to Thursday, one day after Lowe exited his team’s game against the Boston Red Sox.

Lowe took an awkward swing while striking out against Boston starter Brayan Bello in the first inning. He was replaced by Jonny DeLuca when his turn came to bat in the second inning.

Lowe, 26, reportedly has been dealing with injuries to his right hamstring, right oblique and left hip since spring training.

Batting .240 with two home runs and three RBIs in 14 games this season, Lowe is hitting .271 with 24 homers and 99 RBIs in 203 career games with the Rays.

Also on Saturday, the Rays reinstated right-hander Chris Devenski from the 15-day injured list. He had been sidelined due to right knee tendonitis.

Devenski, 33, is 1-1 with a 7.71 ERA, six walks and 11 strikeouts in 14 innings over nine relief appearances.

He is 26-22 with eight saves, a 3.93 ERA in 293 career games (seven starts) for the Houston Astros (2016-20), Arizona Diamondbacks (2021-22), Philadelphia Phillies (2022), Los Angeles Angels (2023) and Rays.

–Field Level Media

spot_img

Related articles

MLB: Reports: Cubs finalizing deal with RHP Zac Gallen

The Chicago Cubs are finalizing a multi-year contract with free agent right-hander Zac Gallen, multiple outlets reported. ESPN gave...

MLB: Red Sox acquire RHP Johan Oviedo from Pirates

The Boston Red Sox continued remaking their rotation on Thursday, acquiring right-hander Johan Oviedo in a trade with...

MLB: Report: Ron Washington joining Giants’ coaching staff

Veteran manager Ron Washington is finalizing a deal to join the San Francisco Giants as their infield coach,...

MLB: Reports: LHP Anthony Kay returning to MLB with White Sox

Left-hander Anthony Kay and the Chicago White Sox have reached agreement on a two-year, $12 million contract, according...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.